|
イチハラ ユウキ
ICHIHARA Yuuki
市原 有起 所属 医学部 医学科（東京女子医科大学病院） 職種 講師 |
|
| 論文種別 | その他 |
| 言語種別 | 英語 |
| 査読の有無 | 査読なし |
| 表題 | Cardiogenic shock severity predicts bleeding events in patients with temporary mechanical circulatory support. |
| 掲載誌名 | 正式名：Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 略 称：Catheter Cardiovasc Interv ISSNコード：1522726X/15221946 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 104(7),pp.1508-1516 |
| 著者・共著者 | Oyabu Kenjiro†, Hattori Hidetoshi, Kikuchi Noriko, Haruki Shintaro, Minami Yuichiro, Ichihara Yuki, Saito Satoshi, Nunoda Shinichi, Niinami Hiroshi, Yamaguchi Junichi |
| 発行年月 | 2024/12 |
| 概要 | BACKGROUND:Data on shock severity and bleeding events in patients with temporary mechanical circulatory support (tMCS) are limited. We investigated the relationship between the Society for Cardiovascular Angiography and Interventions (SCAI) shock stage classification and bleeding events in patients with tMCS.METHODS:We evaluated the data of 285 consecutive patients with tMCS who were admitted to our institution between June 2019 and May 2022. At the time of tMCS initiation, 81 patients (28.4%) were in SCAI stage A, 38 (13.3%) in stage B, 69 (24.2%) in stage C, 33 (11.6%) in stage D, and 64 (22.5%) in stage E. Multivariable logistic regression modeling was used to assess the association between the SCAI shock stage and in-hospital bleeding events.RESULTS:In-hospital bleeding occurred in 100 patients (35.1%). The bleeding event rate increased incrementally across the SCAI shock stages (stage A, 11.1%; stage B, 15.8%; stage C, 37.7%; stage D, 54.6%; stage E, 64.1%). In-hospital bleeding was associated with the SCAI shock stage (p < 0.001). Compared with stage A, the adjusted odds ratios for in-hospital bleeding were 1.48 (95% confidence interval [CI] 0.47-4.66), 6.47 (95% CI 2.61-10.66), 11.59 (95% CI 3.77-35.64), and 7.85 (95% CI 2.51-24.55) for stages B, C, D, and E, respectively.CONCLUSIONS:The SCAI shock stage predicted subsequent bleeding events in patients with tMCS. This simple scheme may be useful for tailored risk-based clinical assessment and management of patients with tMCS. |
| DOI | 10.1002/ccd.31219 |
| PMID | 39219443 |